Power Moves: University of Maryland, Baltimore appoints new medical dean

Power Moves is a column where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us: baltimore@technical.ly.

UMB has a new dean of medicine

Dr. Mark T. Gladwin has been named the new dean of the University of Maryland School of Medicine at the University of Maryland, Baltimore.

“The search committee was impressed by not only his experience, but also his vision for the future of medicine and the role of the medical school in today’s society,” said Dr. Claire M. Fraser, a professor of medicine and director of the Institute for Genome Sciences who chaired the search committee, in a statement.

As dean, he will be responsible for sustaining UMB’s core values and promoting and enhancing diversity, equity and inclusion at UMSOM while leading advances and innovation in the areas of education, research and clinical care.

Gladwin brings experience from the University of Pittsburgh, where he chaired the department of medicine. In that job, he oversaw more than 800 faculty members and was a prolific researcher (with more than 470 manuscripts since 1996) in the fields of vascular and nitric oxide biology.

“I could not be more pleased to announce Dr. Gladwin as the next dean of the University of Maryland School of Medicine,” Dr. Bruce Jarrell, president of UMB, said in a statement. “I am confident he will continue to enrich the legacy of our School of Medicine and position our world-class institution to meet the challenges of the future.”

Medcura appoints new CMO on Series A’s heels

Riverdale-based medical device company Medcura has appointed Dr. Kenneth Renkens as its chief medical officer. Following the company’s $7.4M Series A, this hire of a seasoned medical device vet shows the company’s drive to scale.

“His purposeful style is a great match for our growing team and Surgical Program,”  CEO Larry Tiffany said in a statement. “His careful guidance of Medcura’s clinical evaluation of surgical hemostats will be critical to the success of our lead surgical product as we bring a new class of easy to use, reliable hemostat to the OR with groundbreaking affordability for use, in what we believe could potentially be used in almost every surgical case.”

Renkens is a neurosurgeon that previously cofounded Indiana Spine Group, a multi-specialty spinal surgery practice. That experience will help guide Medcura as it continues to scale.

“I was impressed with the recent published results demonstrating the efficacy and safety of Medcura’s flowable implantable technology in treating severe traumatic field injuries,” Renkens said in a statement. “When combined with Medcura’s experience in delivering their already FDA-cleared technology for consumer use, I clearly saw a foundation for clinical implementation in the [operating room]. I’m excited to help this remarkable team get to the final preclinical evaluation of its lead surgical product that will support a registrational clinical trial in neuro, cardio and general surgical applications.”

Dragos appoints operational technology cert director

Dawn Cappelli. (Courtesy photo)

Hanover-based industrial cybersecurity company Dragos appointed Dawn Cappelli as its director for operational technology certification. She’ll lead Dragos’s OT Cyber Emergency Response Team (OT CERT) certification program, which will serve as a community resource center.

“I’m looking forward to working with Dragos’s exemplary leadership team to build the new OT CERT into a world-class resource center that serves both Dragos customers and the greater ICS/OT community to bring about better awareness and preparedness for the safety and security of industrial infrastructure,” Cappelli said in a statement. “I’m especially excited about the opportunity to provide resources for small and medium-sized companies in protecting their ICS environments.”

Cappelli comes with prior experience as director and founder of the CERT Insider Threat Center at Carnegie Mellon University’s Software Engineering Institute.